Search research articles
Contact Us
Filters
Showing results (471-480 of 535) with videos related to
Page
of 54
Sort By:
The Lancet. Gastroenterology & Hepatology
|
December 10, 2021
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial
Julien D Schulberg, Emily K Wright, Bronte A Holt, et al.
Nature
|
May 22, 2024
Author Correction: A high-density and high-confinement tokamak plasma regime for fusion energy
S Ding, A M Garofalo, H Q Wang, et al.
Nature
|
April 24, 2024
A high-density and high-confinement tokamak plasma regime for fusion energy
S Ding, A M Garofalo, H Q Wang, et al.
Alimentary Pharmacology & Therapeutics
|
February 20, 2016
Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis
N A Kennedy, B Warner, E L Johnston, et al.
Bulletin of the World Health Organization
|
August 2, 2001
Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China
H H Yang, C G Wu, G Z Xie, et al.
Journal of Crohn'S & Colitis
|
January 5, 2025
A new protocolized treatment strategy optimizing medical and surgical care leads to improved healing of Crohn's perianal fistulas
Michael De Gregorio, Leon S Winata, Imogen Hartley, et al.
Internal Medicine Journal
|
September 5, 2024
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy
Natalie Yu, Tanya Lee, Daniel Tassone, et al.
Nature Communications
|
March 2, 2021
Integration of full divertor detachment with improved core confinement for tokamak fusion plasmas
L Wang, H Q Wang, S Ding, et al.
Alimentary Pharmacology & Therapeutics
|
December 21, 2016
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study
J D Doecke, F Hartnell, P Bampton, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 14, 2021
Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal Fistulas
Michael De Gregorio, Tanya Lee, Krupa Krishnaprasad, et al.
Page
of 54
Search research articles
Search
Showing results (471-480 of 535) with videos related to
Sort By:
Page
of 54
The Lancet. Gastroenterology & Hepatology
|
December 10, 2021
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial
Julien D Schulberg, Emily K Wright, Bronte A Holt, et al.
Nature
|
May 22, 2024
Author Correction: A high-density and high-confinement tokamak plasma regime for fusion energy
S Ding, A M Garofalo, H Q Wang, et al.
Nature
|
April 24, 2024
A high-density and high-confinement tokamak plasma regime for fusion energy
S Ding, A M Garofalo, H Q Wang, et al.
Alimentary Pharmacology & Therapeutics
|
February 20, 2016
Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis
N A Kennedy, B Warner, E L Johnston, et al.
Bulletin of the World Health Organization
|
August 2, 2001
Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China
H H Yang, C G Wu, G Z Xie, et al.
Journal of Crohn'S & Colitis
|
January 5, 2025
A new protocolized treatment strategy optimizing medical and surgical care leads to improved healing of Crohn's perianal fistulas
Michael De Gregorio, Leon S Winata, Imogen Hartley, et al.
Internal Medicine Journal
|
September 5, 2024
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy
Natalie Yu, Tanya Lee, Daniel Tassone, et al.
Nature Communications
|
March 2, 2021
Integration of full divertor detachment with improved core confinement for tokamak fusion plasmas
L Wang, H Q Wang, S Ding, et al.
Alimentary Pharmacology & Therapeutics
|
December 21, 2016
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study
J D Doecke, F Hartnell, P Bampton, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 14, 2021
Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal Fistulas
Michael De Gregorio, Tanya Lee, Krupa Krishnaprasad, et al.
Page
of 54